FREQUENCY OF MALARIAL RECURRENCE IN THE PAEDIATRIC DEPARTMENT OF LYARI GENERAL HOSPITAL KARACHI

Authors

  • . RUMAISA Department of Paediatrics, Shaheed Mohtarama Benazir Bhutto Medical College Lyari Karachi, Pakistan
  • R NAWAZ Department of Paediatrics, Shaheed Mohtarama Benazir Bhutto Medical College Lyari Karachi, Pakistan
  • S FATIMA Department (Gynae and Obs Unit-2) Shaheed Mohtarama Benazir Bhutto Medical College Lyari Karachi
  • A REHMAN Department (Gynae and Obs Unit-2) Shaheed Mohtarama Benazir Bhutto Medical College Lyari Karachi
  • A USMAN Department of Paediatrics, Shaheed Mohtarama Benazir Bhutto Medical College Lyari Karachi, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1314

Keywords:

Child, Malaria, Plasmodium falciparum, Plasmodium vivax, Recurrence

Abstract

Malaria remains a significant health burden, especially in pediatric populations, with recurrence posing a substantial challenge. Plasmodium vivax is the predominant species responsible for recurrent malaria episodes. Understanding recurrence rates and associated factors is crucial for designing effective interventions to minimize the disease burden in endemic regions. Objective: To determine the recurrence rate of malaria and associated factors in children aged 2-12 years at the Pediatric Department of Sindh Government Lyari General Hospital, Karachi. Methods: A cross-sectional study was conducted over six months. A sample size of 95 was calculated using Open Epi, based on a 9.78% recurrence rate with a 95% confidence interval and a 7% margin of error. Non-probability consecutive sampling was used. Children aged 2-12 years diagnosed with malaria were included, and those with life-threatening comorbidities were excluded. Demographic data, presenting complaints, and clinical findings were recorded. Malaria diagnosis and Plasmodium species identification were confirmed through blood film microscopy, and treatment adherence was observed. Follow-up for recurrence was conducted over three months, with data analysis performed using SPSS Version 25. Results: The mean age of participants was 6.8 ± 2.5 years, with 52% male and 48% female. Common symptoms included fever (90%), chills (75%), and sweating (68%). Plasmodium vivax was identified in 70% of cases, P. falciparum in 25%, and mixed infections in 5%. The total recurrence rate was 10%, primarily due to P. vivax (60%), with recurrences observed across the three follow-up months. Higher recurrence rates were noted in younger children (2-5 years) and those with non-adherence to the treatment protocol (11%). Conclusion: It is concluded that malaria recurrence in children, particularly in those aged 2-5 years, is a notable issue, with Plasmodium vivax being the predominant species in recurrent cases. High adherence to treatment protocols may help reduce recurrence, while targeted follow-up in high-risk groups could improve outcomes.

Downloads

Download data is not yet available.

References

Talapko J, Škrlec I, Alebić T, Jukić M, Včev A. Malaria: the past and the present. Microorganisms. 2019;7(6):179.

Gozalo AS, Robinson CK, Holdridge J, Mahecha OFL, Elkins WR. Overview of Plasmodium spp. and Animal Models in Malaria Research. Comparative Medicine. 2024;74(4):205-30.

Organization WH. World malaria report 2023: World Health Organization; 2023.

Organization WH. WHO guidelines for malaria, 3 June 2022. World Health Organization; 2022.

Ullah H, Khan MIU, Suleman SK, Javed S, Qadeer A, Nawaz M, et al. Prevalence of malaria infection in district Dir lower, Pakistan. Punjab University Journal of Zoology. 2019;34(2):137-41.

Qureshi NA, Fatima H, Afzal M, Khattak AA, Nawaz MA. Occurrence and seasonal variation of human Plasmodium infection in Punjab Province, Pakistan. BMC infectious diseases. 2019;19:1-13.

Shaikh S, Ahmed I, Memon SM, Saleem A, Memon H, Babar A. Therapeutic Efficacy and Safety of Dihydroartemisinin-Piperaquine (DP) for the Treatment of Uncomplicated Plasmodium Vivax Malaria: A Single Center Study. Journal of Liaquat University of Medical & Health Sciences. 2017;16(2).

Ahmed A, Mulatu K, Elfu B. Prevalence of malaria and associated factors among under-five children in Sherkole refugee camp, Benishangul-Gumuz region, Ethiopia. A cross-sectional study. PloS one. 2021;16(2):e0246895.

Asif AM, Tahir MR, Arshad IA. Socioeconomic condition and prevalence of malaria fever in Pakistani children: findings from a Community Health Survey. Journal of Tropical Pediatrics. 2018;64(3):189-94.

Kotepui M, Punsawad C, Kotepui KU, Somsak V, Phiwklam N, PhunPhuech B. Prevalence of malarial recurrence and hematological alteration following the initial drug regimen: a retrospective study in Western Thailand. BMC Public Health. 2019;19:1-8.

Lawpoolsri S, Sattabongkot J, Sirichaisinthop J, Cui L, Kiattibutr K, Rachaphaew N, et al. Epidemiological profiles of recurrent malaria episodes in an endemic area along the Thailand-Myanmar border: a prospective cohort study. Malaria Journal. 2019;18:1-11.

Patriani D, Arguni E, Kenangalem E, Dini S, Sugiarto P, Hasanuddin A, et al. Early and late mortality after malaria in young children in Papua, Indonesia. BMC infectious diseases. 2019;19:1-13.

Mahittikorn A, Masangkay FR, Kotepui KU, Milanez GDJ, Kotepui M. The high risk of malarial recurrence in patients with Plasmodium-mixed infection after treatment with antimalarial drugs: a systematic review and meta-analysis. Parasites & vectors. 2021;14(1):280.

Hossain MS, Commons RJ, Douglas NM, Thriemer K, Alemayehu BH, Amaratunga C, et al. The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network. PLoS medicine. 2020;17(11):e1003393.

Commons RJ, Simpson JA, Thriemer K, Hossain MS, Douglas NM, Humphreys GS, et al. Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2019;19(1):91-101.

van Der Pluijm RW, Tripura R, Hoglund RM, Phyo AP, Lek D, Ul Islam A, et al. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. The Lancet. 2020;395(10233):1345-60.

Ketema T, Bacha K, Getahun K, Bassat Q. In vivo efficacy of anti-malarial drugs against clinical Plasmodium vivax malaria in Ethiopia: a systematic review and meta-analysis. Malaria Journal. 2021;20:1-19.

Downloads

Published

2024-12-20

How to Cite

RUMAISA, ., NAWAZ, R., FATIMA, S., REHMAN , A., & USMAN, A. (2024). FREQUENCY OF MALARIAL RECURRENCE IN THE PAEDIATRIC DEPARTMENT OF LYARI GENERAL HOSPITAL KARACHI. Biological and Clinical Sciences Research Journal, 2024(1), 1314. https://doi.org/10.54112/bcsrj.v2024i1.1314

Most read articles by the same author(s)

<< < 1 2 3